> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Torrent Pharmaceuticals FDA-483
- URL: https://www.fdaweb.com/torrent-pharmaceuticals-fda-483-3/
- Published: 2022-10-19T12:00:00.000Z
- Updated: 2026-09-14T18:03:40.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5153007

FDA has released the form FDA-483 issued following a 9/19-9/28 inspection at Torrent Pharmaceuticals, Indrad, Gujarat, India, a finished product and active pharmaceutical ingredient manufacturer. The three inspection observations were:

- equipment and utensils are not cleaned and maintained at appropriate intervals to prevent contamination that would alter the safety, identity, strength, quality, or purity of the drug product;
- failing to thoroughly review any unexplained discrepancy and the failure of a batch or any of its components to meet any of its specifications whether or not the batch has been already distributed; and
- failing to have written records of a drug complaint to include the findings of the investigation and the follow-up.